Atazanavir Capsule
NDC Package 42385-920-60
Package Information
Atazanavir capsules is a medication used with other HIV medications to help control HIV infection. This formulation utilizes a capsule delivery system. Marketed by Laurus Labs Limited, this product is identified by NDC 42385-920 and is authorized under FDA application ANDA212579.
Identification & Billing
- RxCUI: 402246 - atazanavir sulfate 150 MG Oral Capsule
- RxCUI: 402246 - atazanavir 150 MG Oral Capsule
- RxCUI: 402246 - atazanavir 150 MG (as atazanavir sulfate 170.8 MG) Oral Capsule
- RxCUI: 402247 - atazanavir sulfate 200 MG Oral Capsule
- RxCUI: 402247 - atazanavir 200 MG Oral Capsule
Clinical Specifications
- Cytochrome P450 2C8 Inhibitors - [MoA] (Mechanism of Action)
- Cytochrome P450 3A Inhibitors - [MoA] (Mechanism of Action)
- Cytochrome P450 3A4 Inhibitors - [MoA] (Mechanism of Action)
- HIV Protease Inhibitors - [MoA] (Mechanism of Action)
- Protease Inhibitor - [EPC] (Established Pharmacologic Class)
- UDP Glucuronosyltransferases Inhibitors - [MoA] (Mechanism of Action)
- UGT1A1 Inhibitors - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 42385 - Laurus Labs Limited
- 42385-920 - Atazanavir
- 42385-920-60 - 60 CAPSULE in 1 BOTTLE
- 42385-920 - Atazanavir
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (42385-920). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 42385-920-60 identifies a specific commercial package of 60 capsule in 1 bottle of Atazanavir, a human prescription drug labeled by Laurus Labs Limited. This product is billed for "EA" each discreet unit and contains an estimated amount of 60 billable units per package. This capsule is formulated for oral use and contains atazanavir sulfate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Laurus Labs Limited on April 30, 2021. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This drug is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Atazanavir belongs to a class of drugs known as protease inhibitors. It may be given with certain other medications (such as cobicistat, ritonavir) to increase ("boost") the levels of atazanavir. This helps atazanavir work better. Atazanavir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, do all of the following: (1) continue to take all HIV medications exactly as prescribed by your doctor, (2) always use an effective barrier method (latex or polyurethane condoms/dental dams) during all sexual activity, and (3) do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.
How is this Laurus Labs Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 42385092060. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.